05 Compliance

The regulatory file for N-acetyl glucosamine

Technical document 05 · Reviewed 2026-11-19 · N-Acetyl Glucosamine

On this page
  1. What the file has to answer
  2. European Union
  3. United States
  4. Contaminants and limits
  5. Label and claims
  6. Documents in the file
  7. Checklist before the first order

N-Acetyl glucosamine is supplied as N-acetyl-D-glucosamine, CAS 7512-17-6. The catalog specification describes the powder; the regulatory file describes the route, the limits and the label that apply where the product will be sold. Whether a market requires a novel-food authorisation, a supplement notification or another basis is a determination for the buyer's regulatory team, and it should be settled before the label is written. This page lists the questions and documents that file has to answer.

In one line

The specification describes the powder, the destination decides the route, and the buyer's regulatory team confirms whether NAG needs a novel-food entry, a supplement notification or another basis.

What the file has to answer

The file answers four questions, and each one needs a different document. What is the substance, and which version of the specification is being purchased? Which lot is being released, and what did its certificate measure? Which route and labelling rules apply in the destination, and to the finished product rather than the drum? And what happens to the file if the source, process or pack changes? The certificate speaks to the lot, the technical data sheet to the specification, the safety data sheet to handling; none of the three establishes the route.

The file also needs the source declaration, the allergen statement, the GMO statement, the origin file, the residual-solvent declaration and any customer-specific statement. A missing document is easier to fix before the order than at the port, so list what is present and what is still outstanding. Keep the list versioned: a folder of undated PDFs is hard to audit. The framework summary below reflects this review, and the current legal text governs.

European Union

The EU file starts with the material and works outward to the label. General food law, the food information rules and the nutrition and health claims rules apply in addition to any product-specific route. Whether NAG falls under the novel-food regime, or is covered by an existing entry, turns on the source, the specification and the date of the assessment. Some markets have a product-specific entry for a defined NAG form; confirm the current text and its conditions. The buyer's regulatory team confirms the route for the member state concerned and keeps the evidence with the order.

Labelling is reviewed separately. A shellfish-derived lot brings the crustacean shellfish allergen into the finished-product assessment; a fermentation-derived lot brings a different source statement but not an automatic exemption from the allergen review of the whole formula. The declared ingredient should read N-acetyl glucosamine, not glucosamine.

United States

On the US market, a dietary ingredient is sold under the dietary-supplement framework. Whether this substance is an old dietary ingredient or needs a new dietary ingredient notification is for the buyer's regulatory team to decide; this page asserts neither status. The supplier supplies the identity, source, specification and safety material that the file or a notification would use, and the buyer checks that the basis extends to the finished product and to the claim.

The Supplement Facts panel declares the dietary ingredient, and the abbreviation “NAG” is not enough on its own; the full name should appear. For a shellfish-derived lot, the crustacean shellfish declaration is considered under the US allergen rules. A conventional-food use follows a different route, and nothing here implies a food-additive or GRAS basis.

Contaminants and limits

The limits in the catalog apply to the ingredient. The finished-product figure depends on the dose and on the destination's maximum levels, so the file should show the calculation as well as the lot result. The table is a starting point, not a substitute for the current text.

Catalog limits and the evidence the file should hold
ParameterCatalog limitWhat the file should show
Lead (Pb)≤3 mg/kgThe numeric result, the method, and the arithmetic at the finished dose
Arsenic (As)≤2 mg/kgThe result and the method
Cadmium (Cd)≤1 mg/kgThe result and any category exception
Mercury (Hg)≤0.1 mg/kgThe result and the method
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentColony count plus the absence result
Free glucosamineNo catalog limitOnly if agreed: a limit and its method

Label and claims

No disease-related claim is made on this page. The label declares the material and its quantity in the form the destination requires, and the claim review follows separately: the brand's reviewer checks that the wording fits the product, the form and the market. A certificate does not authorise a claim, and a claim does not amend the specification.

The ingredient name is part of that review. Describing NAG as glucosamine, or expressing a NAG dose as a glucosamine figure, misnames the substance and creates a labelling defect that no certificate can fix. Where a destination has a product-specific entry for NAG, the label and the conditions of use must match it as well as the general labelling rules.

Documents in the file

  • Specification document: revision number, CAS 7512-17-6, source and mesh.
  • Lot certificate covering assay, rotation, moisture, pH, metals and microbiology.
  • Technical data sheet, plus the safety data sheet for handling.
  • Source and allergen file: shellfish species and origin, or the fermentation route and its processing aids.
  • GMO position, country of origin and residual-solvent statement.
  • Stability summary for the pack being quoted.
  • Free-glucosamine result where a limit has been agreed.
  • Change-control record for source, process and pack.

Checklist before the first order

  • Check that the specification carries a version date, the CAS number 7512-17-6 and the shellfish or fermentation source.
  • Confirm the pack contains the lot COA, the TDS and SDS, the source and allergen declarations, GMO and origin records and the residual-solvent statement.
  • Recalculate the lead, arsenic, cadmium and mercury results for the actual daily dose of the finished product.
  • Confirm that the label names N-acetyl glucosamine and that no claim outruns the destination's rules.
  • Keep the buyer's written route confirmation with the purchase order.
  • Record any change of source, process or pack before the next lot ships.

Catalog ranges are published on the NAG product page. For the lot document see the COA page; for the analytical evidence the identity page; for the separate glucosamine ingredient, its own product page. The EU regulatory note gives the framework references; the quality page explains how the release file is assembled.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation